Know Your Legal Rights

Seth Nehrbass When someone mentions scientists and lawyers in the same breath, one of the first images that comes to mind could be expert witnesses poring over complex graphs of DNA evidence, as in the O.J. Simpson trial. But the legal matters that concern most researchers are much more mundane--intellectual property law, employment agreements, and the like, not the stuff of sensationalistic headlines. In general, scientists have no clue about the law and how it affects their work, say attorneys

Written byKaren Young Kreeger
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share


Seth Nehrbass
When someone mentions scientists and lawyers in the same breath, one of the first images that comes to mind could be expert witnesses poring over complex graphs of DNA evidence, as in the O.J. Simpson trial. But the legal matters that concern most researchers are much more mundane--intellectual property law, employment agreements, and the like, not the stuff of sensationalistic headlines. In general, scientists have no clue about the law and how it affects their work, say attorneys and technology transfer specialists. To be fair, "They're just not trained to do that," says Seth Nehrbass, a patent attorney with Garvey, Smith, Nehrbass & Doody in New Orleans, La., who works with researchers.

Still, there are many areas that can impinge on a researcher's work: patent and licensing rights, trade secret issues, and copyright law, for example. These areas vary somewhat between academia and industry. For instance, if a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies